Latest fiscal year 2023 · computed deterministically from XBRL 10-K data · coverage 100%
In fiscal 2023, ELECTROMEDICAL TECHNOLOGIES, INC. reported revenue of $1M, up 17.3% year over year. Operating margin was -153.1% and net margin -195.8%, on a free-cash-flow margin of -116.2% with capital expenditure at 11.1% of revenue. Every figure is computed directly from EMED's SEC XBRL 10-K filing — deterministic, with no estimates.
| Fiscal year | Revenue | Op margin | Net margin |
|---|---|---|---|
| FY2023 | $1M | -153.1% | -195.8% |
| FY2022 | $1M | -139.5% | -301.6% |
| FY2021 | $1M | -418.8% | -934.6% |
| FY2020 | $1M | -429.1% | -524.7% |
| FY2019 | $1M | -201.1% | -210.2% |
How does EMED compare against its actual peer set?
A CompsDesk subscription covers unlimited benchmark packs on any covered company: up to 19 metrics (6 core guaranteed) × up to 5 fiscal years × up to 12 chosen peers, percentile placement, the subject's figures cited to their SEC tag, form and period with every company identified by its CIK, PDF-ready HTML + CSV, generated on demand.
Source: SEC EDGAR XBRL (10-K filings), latest filed values. "n/a" = not disclosed under mapped tags — never estimated. Informational benchmarking, not investment advice. © CompsDesk / Sam Arora.